Completed PHASE1 INTERVENTIONAL 3-arm NCT01272674

Adiponectin and Circulating Progenitor Cells (CPC) Function

Adiponectin Promotes the Migration of Circulating Progenitor Cells Through p38-mediated Induction of the CXCR4 Receptor

Sponsor: German Research Foundation

Updated 7 times since 2017 Last updated: Jun 1, 2015 Started: Jan 31, 2011 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01272674, this PHASE1 trial focuses on Coronary Artery Disease and remains completed. Sponsored by German Research Foundation, it has been updated 7 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1
Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Sep 2018 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

German Research Foundation
Heart Center Leipzig - University Hospital
University of Leipzig

Data source: University of Leipzig

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leipzig, Germany